These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; ; Pediatrics; 2009 Aug; 124(2):823-36. PubMed ID: 19581259 [TBL] [Abstract][Full Text] [Related]
29. Temporal trends in survival among infants with critical congenital heart defects. Oster ME; Lee KA; Honein MA; Riehle-Colarusso T; Shin M; Correa A Pediatrics; 2013 May; 131(5):e1502-8. PubMed ID: 23610203 [TBL] [Abstract][Full Text] [Related]
30. Identification of Critical Congenital Heart Disease in Vermont: The Role of Universal Pulse Oximetry Screening in a Rural State. Good RJ; Canale SK; Goodman RL; Yeager SB Clin Pediatr (Phila); 2015 Jun; 54(6):570-4. PubMed ID: 25398625 [TBL] [Abstract][Full Text] [Related]
31. Use of Pulse Oximetry Pulsatility Index Screening for Critical Congenital Heart Disease. Rasmussen M; Suttner D; Poeltler D; Katheria AC Am J Perinatol; 2024 May; 41(S 01):e545-e549. PubMed ID: 35858650 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns. Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890 [TBL] [Abstract][Full Text] [Related]
34. [Pulse oximetry screening of critical congenital heart defects in the neonatal period. The Spanish National Neonatal Society recommendation]. Sánchez Luna M; Pérez Muñuzuri A; Sanz López E; Leante Castellanos JL; Benavente Fernández I; Ruiz Campillo CW; Sánchez Redondo MD; Vento Torres M; Rite Gracia S; An Pediatr (Engl Ed); 2018 Feb; 88(2):112.e1-112.e6. PubMed ID: 28965726 [TBL] [Abstract][Full Text] [Related]
35. Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community. Miller KK; Vig KS; Goetz EM; Spicer G; Yang AJ; Hokanson JS J Perinatol; 2016 Dec; 36(12):1088-1091. PubMed ID: 27583398 [TBL] [Abstract][Full Text] [Related]
36. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; Circulation; 2009 Aug; 120(5):447-58. PubMed ID: 19581492 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of critical congenital heart defects screening using pulse oximetry in the neonatal intensive care unit. Van Naarden Braun K; Grazel R; Koppel R; Lakshminrusimha S; Lohr J; Kumar P; Govindaswami B; Giuliano M; Cohen M; Spillane N; Jegatheesan P; McClure D; Hassinger D; Fofah O; Chandra S; Allen D; Axelrod R; Blau J; Hudome S; Assing E; Garg LF J Perinatol; 2017 Oct; 37(10):1117-1123. PubMed ID: 28749481 [TBL] [Abstract][Full Text] [Related]
39. The value of peripheral perfusion index measurements for early detection of critical cardiac defects. Uygur O; Koroglu OA; Levent E; Tosyali M; Akisu M; Yalaz M; Kultursay N Pediatr Neonatol; 2019 Feb; 60(1):68-73. PubMed ID: 29776787 [TBL] [Abstract][Full Text] [Related]
40. Pulse oximetry as a screening test for critical congenital heart disease in term newborns. Gómez-Rodríguez G; Quezada-Herrera A; Amador-Licona N; Carballo-Magdaleno D; Rodríguez-Mejía EJ; Guízar-Mendoza JM Rev Invest Clin; 2015; 67(2):130-4. PubMed ID: 25938847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]